Related Experiment Videos
Quality of life assessment
1Institute for Scientific Research of Stress, PHRF, Nishiyama Kogyo Ochanomizu Building 5F, 1-2-13, Yushima, Bunkyo-ku, Tokyo 113-0034, Japan. shimozuma@jmari.med.or.jp
Breast Cancer (Tokyo, Japan)
|May 23, 2002
Summary
Oncologists need better understanding of health-related quality of life (HRQOL) assessments in cancer care. This article guides on choosing and validating QOL instruments for improved clinical trial outcomes.
Area of Science:
- Oncology
- Psychometrics
- Health Services Research
Background:
- Health-related quality of life (HRQOL) is crucial in cancer treatment evaluation.
- Many oncologists lack a deep understanding of QOL assessment principles and applications.
- Standardized QOL measures are essential for robust clinical trial data.
Purpose of the Study:
- To elucidate key psychometric properties for validating QOL instruments.
- To define the scope of QOL concepts relevant to oncology.
- To provide guidance on selecting appropriate QOL measures and address statistical and cross-cultural validation challenges.
Main Methods:
- Literature review of QOL assessment principles in oncology.
- Discussion of psychometric validation criteria (reliability, validity, responsiveness).
- Analysis of QOL concepts pertinent to cancer patients.
- Review of QOL measures used in recent oncology clinical trials.
Main Results:
- Identified essential psychometric properties for QOL instruments.
- Outlined the scope of QOL assessment in oncology.
- Provided criteria for selecting appropriate QOL measures.
- Highlighted challenges in cross-cultural validation and statistical analysis.
Conclusions:
- Enhanced understanding and application of QOL assessments are vital for oncologists.
- Careful selection and validation of QOL instruments improve cancer treatment evaluation.
- Addressing psychometric, statistical, and cultural factors ensures reliable QOL data in oncology research.